Applicant, as named in the Orange Book

Hong Kong

Next listed expiry: Xenleta on 25 Mar 2033. 2 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Xenleta lefamulin acetate	lefamulin acetate	211672	25 Mar 2033	patent
Xenleta lefamulin acetate	lefamulin acetate	211673	14 Jun 2036	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.